Cellgenix USA:1234061 [pots: 18-002498]

Ended Purchase Order Awarded Last action

Contract number
75N90018P00375
Awardee
Awarding agency
Obligated
$103,103

Award facts

Opportunity
Contract value 100% obligated
$103,103.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Amarillo, TX 79108, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $51,552
Original award $51,552

About this award

The National Institutes of Health Clinical Center awarded a purchase order to Cellgenix USA for $103,103.00 on April 5, 2018, with completion by April 4, 2019. Place of performance is Amarillo, Texas. The order procures cell and gene therapy raw materials and ancillary pharmaceuticals, including cytokines, growth factors, and interleukins for research and development support. Firm fixed price.

Quick answers

Who was awarded contract 75N90018P00375?

75N90018P00375 was awarded to Cellgenix USA by NIH Clinical Center (National Institutes of Health) on April 5, 2018.

How much is contract 75N90018P00375 worth?

The government has obligated $103,103 on 75N90018P00375.

Was contract 75N90018P00375 competed?

The extent of competition for 75N90018P00375 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award